Directory
>
Richard Mulligan
Richard Mulligan
Assistant Professor of Molecular Biology | Sana Biotechnology, Inc.
New York City Metropolitan Area United States, United States
Richard Mulligan
Summary
Richard Mulligan is a distinguished academic and business leader with extensive experience in genetics and biotechnology. As the Mallinckrodt Professor of Genetics, Emeritus at Harvard, he has made significant contributions to the field of molecular biology. His current role as Vice Chairman and Head of Sana X at Sana Biotechnology reflects his commitment to advancing innovative therapies. Additionally, he serves on the board of Biogen, a leading biotechnology company, where he influences strategic decisions. With a strong background in portfolio management at Icahn Capital LP, Richard combines scientific expertise with financial acumen. His work spans both academia and industry, showcasing his versatility in navigating complex challenges. Residing in the New York City Metropolitan Area, he is well-positioned at the intersection of research and investment in biotechnology. Richard's leadership and vision continue to shape the future of genetic research and therapy development. He is passionate about fostering collaboration across disciplines to drive innovation.
Richard Mulligan
Work Experience
Vice Chairman and Head, Sana X at
Sana Biotechnology, Inc.
December 2018 - Present
Frequently Asked Questions about Richard Mulligan
What is Richard Mulligan email address?
Richard Mulligan's primary email address is ****************@harvard.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Richard Mulligan work for?
Richard Mulligan is a Assistant Professor of Molecular Biology at Sana Biotechnology, Inc..
How can I directly contact Richard Mulligan?
To contact Richard Mulligan directly, you can use the email address ****************@harvard.edu. Complete contact information is available upon registration with Muraena.
Who is Richard Mulligan?
Richard Mulligan is a distinguished academic and business leader with extensive experience in genetics and biotechnology. As the Mallinckrodt Professor of Genetics, Emeritus at Harvard, he has made significant contributions to the field of molecular biology. His current role as Vice Chairman and Head of Sana X at Sana Biotechnology reflects his commitment to advancing innovative therapies. Additionally, he serves on the board of Biogen, a leading biotechnology company, where he influences strategic decisions. With a strong background in portfolio management at Icahn Capital LP, Richard combines scientific expertise with financial acumen. His work spans both academia and industry, showcasing his versatility in navigating complex challenges. Residing in the New York City Metropolitan Area, he is well-positioned at the intersection of research and investment in biotechnology. Richard's leadership and vision continue to shape the future of genetic research and therapy development. He is passionate about fostering collaboration across disciplines to drive innovation.
Richard`s contact details
****************@harvard.edu
********@receptor.med.harvard.edu
****************@sana.com
Colleagues
Operations Roles of Increasing Responsibility [Technician to Supervisor]
Senior Director
Research Fellow
Columnist
Intern, Biochemical and Cellular Pharmacology
Postdoctoral Fellow
Formulations scientist
Finance Specialist / Research Operations Specialist
research associate
Sr Scientist & Sr Group Leader